Thanks for logging in.

You can now click/tap WATCH to start the live stream.

Thanks for logging in.

You can now click/tap LISTEN to start the live stream.

Thanks for logging in.

You can now click/tap LATEST NEWS to start the live stream.

LISTEN
Watch
on air now

Create a 3AW account today!

You can now log in once to listen live, watch live, join competitions, enjoy exclusive 3AW content and other benefits.


Joining is easy.

Advertisement
Advertisement
Advertisement

Taskforce recommends Remdesivir as first drug for COVID-19 treatment

CORONAVIRUS LATEST
Article image for Taskforce recommends Remdesivir as first drug for COVID-19 treatment

The National COVID-19 Clinical Evidence Taskforce is recommending the use of Remdesivir to treat people with the coronavirus.

The antiviral drug is the first medication recommended as a considered treatment for hospitalised patients with COVID-19.

Originally developed for the treatment of Ebola, clinical trials show Remdesivir may decrease recovery time in people with moderate, severe or critical COVID-19.

The taskforce comprises 28 peak health professional bodies.

Taskforce boss, Associate Professor Julian Elliott, says that while it’s early days in testing, it is a significant step forward.

He says this is the first information we have that a drug has a beneficial effect as a treatment for COVID-19.

Professor Elliott added that there are now 10 registered trials on the use of Remdesivir in the treatment of the virus.

CORONAVIRUS LATEST
Advertisement